Financial Statements — DCX
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 |
|---|
| Cash & Equivalents | 0.35 | 1.07 |
| Short-term Investments | 40.26 | -- |
| Inventory | 10.03 | 16.72 |
| Total Current Assets | 113.26 | 77.72 |
| Property, Plant & Equipment | 150.70 | 166.41 |
| Goodwill | 2.67 | 2.63 |
| Intangible Assets | 0.00 | 0.02 |
| Total Non-current Assets* | 377.66 | 422.59 |
| Total Assets | 490.91 | 500.31 |
| Total Current Liabilities | 584.08 | 523.61 |
| Total Non-current Liabilities* | 73.12 | 85.11 |
| Total Liabilities | 657.20 | 608.72 |
| Retained Earnings | (401.18) | (335.86) |
| Total Stockholder Equity | (179.58) | (153.99) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 |
|---|
| Total Revenue | 0.60 | 3.41 |
| Cost of Revenue | 6.58 | 7.57 |
| Gross Profit | (7.16) | (12.33) |
| Research & Development | 0.16 | 1.08 |
| Selling, General & Admin | 60.60 | 12.84 |
| Total Operating Expenses | 61.16 | 14.65 |
| Operating Income | (68.32) | (26.98) |
| Interest Expense | 8.20 | -- |
| Pretax Income | (61.49) | (31.52) |
| Net Income | (40.05) | (21.62) |
| Basic EPS | (1.73) | (3.93) |
| Diluted EPS | (1.73) | (3.93) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 |
|---|
| Operating Cash Flow | 1.62 | (16.26) |
| Capital Expenditures | -- | 1.06 |
| Free Cash Flow* | -- | (17.32) |
| Investing Cash Flow | (0.26) | (1.06) |
| Financing Cash Flow | (1.79) | 3.16 |
* Derived from reported values
